METHOD FOR TREATING DOGS WITH MITRAL VALVE ENDOCARDIOSIS Russian patent published in 2021 - IPC A61K31/341 A61K31/345 A61K31/4166 A61P9/10 

FIELD: veterinary medicine.

SUBSTANCE: invention relates to veterinary medicine, in particular to the treatment of internal diseases in animals, and can be used for treating dogs with mitral valve endocardiosis. This is done by prescribing lifetime therapy with pimobendan at a dose of 0.25 mg/kg twice a day, telmisartan at an initial dose of 0.5 mg/kg with an increase after 14 days to 1 mg/kg per day, furosemide at a dose of 3 mg/kg twice a day intravenously to reduce chronic symptoms of cardiosvascular insufficiency followed by oral conversion, spironolactone at a dose of 2 mg/kg 2 times a day.

EFFECT: method enables reducing the symptoms of chronic cardiovascular insufficiency due to the effect of the joint use of preparations on the diastolic function, by improving the relaxation and filling of the left ventricle, and by suppressing the sympathoadrenal and renin-angiotensin-aldosterone system with a significant increase in animal life expectancy.

1 cl, 4 tbl, 5 ex